Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Inventory Average (2016 - 2025)

Historic Inventory Average for China Pharma Holdings (CPHI) over the last 15 years, with Q3 2025 value amounting to $2.7 million.

  • China Pharma Holdings' Inventory Average rose 194.44% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 194.44%. This contributed to the annual value of $3.4 million for FY2024, which is 157.95% down from last year.
  • China Pharma Holdings' Inventory Average amounted to $2.7 million in Q3 2025, which was up 194.44% from $2.7 million recorded in Q2 2025.
  • China Pharma Holdings' Inventory Average's 5-year high stood at $3.8 million during Q3 2023, with a 5-year trough of $2.7 million in Q3 2024.
  • Moreover, its 5-year median value for Inventory Average was $3.2 million (2024), whereas its average is $3.2 million.
  • Per our database at Business Quant, China Pharma Holdings' Inventory Average skyrocketed by 3074.87% in 2023 and then tumbled by 3076.33% in 2024.
  • China Pharma Holdings' Inventory Average (Quarter) stood at $3.0 million in 2021, then dropped by 3.1% to $2.9 million in 2022, then soared by 30.75% to $3.8 million in 2023, then plummeted by 30.02% to $2.7 million in 2024, then increased by 1.54% to $2.7 million in 2025.
  • Its Inventory Average was $2.7 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.8 million in Q1 2025.